Akums Drugs and Pharmaceutical Financial Flexibility Index
Akums Drugs and Pharmaceutical financial flexibility index. Akums Drugs and Pharmaceutical (AKUMS) has a Financial Flexibility Index of 0.64x as of September 2025. Free cash flow of Rs12.64 Billion (operating CF Rs11.52 Billion minus capex Rs1.12 Billion) represents 1% of total liabilities (Rs19.91 Billion). See AKUMS free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Akums Drugs and Pharmaceutical (2022–2026)
Financial flexibility index of Akums Drugs and Pharmaceutical from 2022 to 2026. Historical Financial Flexibility Index trend for Akums Drugs and Pharmaceutical across 5 annual periods. Check Akums Drugs and Pharmaceutical (AKUMS) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Akums Drugs and Pharmaceutical Financial Flexibility Index by Year (2022–2026)
Akums Drugs and Pharmaceutical financial flexibility index by year from 2022 to 2026. Year-by-year free cash flow to debt coverage for Akums Drugs and Pharmaceutical. For the full cash flow conversion analysis, see cash flow conversion of Akums Drugs and Pharmaceutical.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.68x | Rs14.41 Billion | Rs12.11 Billion | Rs21.16 Billion | ▼ -3.0% |
| 2025 | 0.70x | Rs7.38 Billion | Rs4.65 Billion | Rs10.50 Billion | ▲ +142.6% |
| 2024 | 0.29x | Rs8.10 Billion | Rs4.98 Billion | Rs27.96 Billion | ▲ +45.7% |
| 2023 | 0.20x | Rs5.05 Billion | Rs1.77 Billion | Rs25.43 Billion | ▲ +67.8% |
| 2022 | 0.12x | Rs2.89 Billion | Rs318.54 Million | Rs24.44 Billion | — |